Earlier this year, IVI and Thailand’s National Vaccine Institute (NVI) signed a Definitive Agreement to strengthen our longstanding and varied partnership. In addition to pursuing mutual vaccine R&D interests and opportunities, this agreement founded a fellowship program to further encourage collaboration.   Today, we meet […]

Cholera, an ongoing pandemic that has persisted for over a century IVI conducts large-scale vaccination programs at cholera endemic hotspot areas of Ethiopia   There's a pandemic that has continued to afflict humanity for over 100 years. Cholera, which first emerged in 1817, is still […]

Cervical cancer is the fourth most common cancer in women around the world, and nearly all cases are due to human papillomavirus (HPV) infection. While there are several vaccines available to prevent HPV, less than 15% of women are fully vaccinated and coverage is even […]

It’s official: the International Vaccine Institute (IVI) will open a European Regional Office in Stockholm, Sweden this year. This new office marks IVI’s first expansion since the founding of its headquarters in Seoul, Korea in 1997 as a UN treaty-based international organization.   With its […]

March 29, 2022   The COVID-19 pandemic dramatically shifted the landscape of vaccine discovery and development. The scientific community demonstrated an extraordinary ability to innovate and collaborate, developing new vaccines within a year of identifying a new pathogen, new drugs and monoclonal antibodies within months, […]

Dr. Richard Mahoney, who first helped lead the formation of the Children’s Vaccine Initiative and later the establishment of IVI, was on the ground since Day 1 to set up the fledgling international organization and articulate its vision. We had the pleasure of catching up […]

The COVID-19 pandemic was a blunt and universal reminder of the health and social imperative of vaccines. While vaccines may have typically been considered a childhood rite of passage, the global health community was suddenly faced with the unprecedented challenge of inoculating not only hundreds […]

We are pleased to share a joint statement issued by Dr. Joris Vandeputte, President of the International Alliance for Biological Standardization (IABS) and Dr. Jerome Kim, Director General of IVI on the implications of vaccine platform technologies for global public health.   COVID SHOWS PREPAREDNESS IS […]

As 2021 comes to a close, IVI reflects on the work we've accomplished this year in partnership with our global network of collaborators and supporters. From partnering with over two dozen vaccine organizations in Korea and around the world to accelerate COVID-19 vaccines as efficiently […]

Antimicrobial resistance (AMR) is a health and development threat to all people, regardless of country, as well as to animals and the environment. That’s why we need to come together for One Health solutions—bridging human, animal, and environmental health—to preserve the effectiveness of medicines and […]

The Korea International Cooperation Agency’s (KOICA) COVID-19 Information Hub features weekly editorials from field experts who analyze and comment on a range of COVID-19-related topics, including vaccine science and the socio-economic impacts of the pandemic. In her contribution, Dr. Se Eun Park, Ph.D., Research Scientist at […]

The benefit of vaccines often focuses on health and societal benefits, highlighting the prevention of disease, disability, and death, as well as Sustainable Development Goals such as enabling the continuation of work and education, reducing poverty, uplifting economies, and achieving gender equality, among others. At […]

Every year, World Environment Day offers a global platform for inspiring positive change. It pushes for individuals to think about the way they consume; for businesses to develop greener models; for farmers and manufacturers to produce more sustainably; for governments to invest in repairing the […]

Nepal is a signatory of the IVI Establishment Agreement, helping to found IVI as an international organization. Since then, we’ve worked with the Nepalese government, universities, and research organizations on vaccine R&D collaborations and vaccination campaigns to prevent, control, and end the spread of infectious […]

IVI is developing an ongoing video series called Ask a Vaccine Expert to answer common questions related to vaccines and vaccination. How are they made? What’s the difference between them? How do they work? We’ve put out an open call for questions to find out what you want to know and […]

Decreasing the burden of Strep A disease in the most in need The mission of the Strep A Vaccine Global Consortium (SAVAC) is to ensure that safe, effective and affordable Strep A vaccines are available and implemented to decrease the burden of Strep A disease […]

The Korea International Cooperation Agency's (KOICA) COVID-19 Information Hub features weekly editorials from field experts who analyze and comment on a range of COVID-19-related topics, including vaccine science and the socio-economic impacts of the pandemic. In his contribution, Dr. Daniel Chulwoo Rhee, M.D., Research Scientist […]

by Raphaël Zellweger and Aerie Em The externalities of the COVID-19 pandemic In 1962, virologist and Nobel Prize winner Sir Frank Macfarlane Burnet famously said, “To write about infectious diseases is almost to write of something that has passed into history.” Nearly 60 years later, there […]

2020 was an unprecedented year in global health. A novel virus spread to all corners of the world, devastating people's lives, economies, and ways of life, and the scientific community responded with agility and partnership that will inspire vaccine research and development for years to […]

Antimicrobials are an extraordinary medical advancement that have treated people against deadly infections since the early 20th century. However, an overdependence on them and widespread misuse have led to an urgent and growing global health crisis: antimicrobial resistance (AMR), when bacteria, viruses, fungi, and parasites […]

On August 10, 2020, Finland officially joined the International Vaccine Institute (IVI) with an MOU-signing and flag-raising ceremony. Finland became the 36th member state of the Seoul-based international organization dedicated to vaccines for global health in response to the COVID-19 pandemic, committing support for core operations […]

  Orange Life Insurance, a leading insurer (CEO: Munkuk CHEONG), has donated a total of 120 million KRW jointly with 26 professional golfers from LPGA and KLPGA through its annual golf competition to support IVI’s Covid-19 vaccine development efforts.   The donation was raised through […]

  August 6, 2020, SEOUL, South Korea – Ambassador Juan Carlos CAIZA Rosero from the Colombian Embassy in Korea visited the International Vaccine Institute (IVI) today for an overview of IVI’s ongoing COVID-19 vaccine research and development projects, as well as past and present vaccine […]

  August 3, 2020, SEOUL, South Korea – The International Vaccine Institute (IVI) welcomed His Excellency Michael Danagher, Ambassador of Canada to the Koreas, to IVI headquarters today to discuss developments in COVID-19 vaccine research as well as ongoing efforts to sustain programs for long-existing […]

July 30, 2020, SEOUL, South Korea — We were pleased to welcome Dr. Jung Joo Hong, Director of ABSL-3 at the National Primate Research Center, Korea Research Institute of Bioscience and Biotechnology for a seminar on the suitability of macaques as a non-human primate model […]

How COVID-19 vaccine clinical trials currently underway around the world may be the blueprint for future clinical trial designs   The team meets at 8:30 AM every morning for a daily “huddle.” All conversation revolves around a whiteboard filled with due dates, action items, pressing […]

By nature, COVID-19 vaccine development is different from previous projects — Dr. Sang-Hwan Seo, Research Scientist & Lab Manager at IVI, explains why:   Since a couple of months ago, signs have been posted outside of IVI’s biosafety level 3 (BSL-3) facility saying that COVID-19 […]

Originally published in Dong-A Science June 11, 2020   The new candidate COVID-19 vaccine ‘GX-1,’ which is being developed by the Korean biotech company Genexine, has been approved for phase 1 and 2a clinical trials in South Korea. It is the first time that a […]

There is an abundance of resources online and elsewhere related to COVID-19, and it’s important to stay informed on the latest and most accurate facts. Refer to your local and national authorities on the most up-to-date recommendations and restrictions, and touch base with the WHO’s Advice […]

May 22, 2020, SEOUL, South Korea — For our first lecture in our ‘Present and Future of Vaccine Development’ series of 2020, we welcomed Professor V. Narry Kim from Seoul National University to present on the SARS-CoV-2 (the virus causing COVID-19) genome and its transcriptomic architecture. […]

As we globally recognize the first ever World Neglected Tropical Diseases Day, we take this opportunity to specifically raise awareness around Schistosomiasis, a devastating Neglected Tropical Disease (NTD) endemic in 78 low- and middle-income countries.   What is schistosomiasis? Schistosomiasis is a poverty-associated disease caused […]

On December 19, 2019, the Korea Support Committee (KSC) held a donation ceremony to present IVI with a total donation of 423M Korean won (> 365,000 USD) made possible by generous donors across industry, academia, health organizations, and individuals. Major donors and representatives from donating […]

Accelerate vaccines. Decelerate AMR.   Every November, World Antibiotic Awareness Week (WAAW) aims to increase global awareness of antibiotic resistance and to encourage best practices to avoid its further emergence and spread. This year, IVI ran a social media campaign to raise awareness specifically around […]

On November 12, 2019, IVI’s Scientific Advisory Group (SAG) gathered at IVI headquarters in Seoul, Korea for an annual two-day meeting of project presentations, insightful Q&As, and critical engagement. Following the SAG days, the IVI Board of Trustees met for their second face-to-face meeting of […]

IVI hosted a State Forum at their headquarters in Seoul on Friday, October 11, showcasing the impact of international cooperation in vaccine research and development (R&D), and delivery in low- and middle-income countries. The Forum was attended by ambassadors and senior diplomats from 17 countries, […]

  August 23, SEOUL, South Korea. In our seminar series ‘Present and Future of Vaccine Development’, we were happy to welcome our latest speaker: Dr. Dong Wook Kim from the Department of Pharmacy at Hanyang University. Based upon their insight into the genetic alterations in […]

August 11, 2019, SEOUL, South Korea —IVI was honored to once again receive the unwavering support of professional Violinist, Lee Sang Hee & Friends -in addition to that of hundreds of concertgoers, via her annual charity concert.   ‘The 16th Lee Sang Hee Violin Recital […]

July 26, SEOUL, South Korea. In our seminar series ‘Present and Future of Vaccine Development’, we were happy to welcome our latest speaker: Doctor of Veterinary Medicine (DVM), Jong-Hyeon Park, PhD., Head of the Center for FMD Vaccine Research Animal and Plant Quarantine Agency. He […]

Raphas committed to increase contributions to IVI through ‘Giving Vaccine’ campaign   From left to right: Francois Belin, COO of IVI; Prof. Park Sang-chul, President of the Korea Support Committee for IVI; Dr. DoHyeon Jeong, CEO of Raphas   July 25, 2019 – SEOUL, South […]

      July 25, 2019 – SEOUL, South Korea. The International Vaccine Institute (IVI) is pleased to announce that EuBiologics, IVI’s key partner in Korea, received a 900 million Korean won ($760,000) award from the RIGHT Fund for the development of a cholera conjugate […]

    Dr. Jerome Kim (left), Director General of IVI and Dr. Quehn Park, Commander of AFMRI   July 12, 2019 – SEOUL, South Korea. Today IVI exchanged a memorandum of understanding with the Armed Forces Medical Research Institute (AFMRI), the Korean military’s institution dedicated […]

Dr. Andrew Lees, Scientific Director of Fina BioSolutions LLC, giving a seminar at IVI   July 9, 2019, Seoul, South Korea -Dr. Andrew Lees, Scientific Director of Fina BioSolutions LLC, gave a seminar today at IVI headquarters about the road towards affordable conjugate vaccines. During […]

Prof. Yeonhee Lee gives talk on ‘Culture Collection of Antimicrobial Resistant Microbes’   July 1, 2019 – SEOUL, South Korea. Prof. Yeonhee Lee, PhD, a professor at Seoul Women’s University and President of the Microbiological Society of Korea, delivered a lecture entitled: “Culture Collection of Antimicrobial-Resistant Microbes” on […]

Dr. Jerome Kim (left), General Director of IVI and Mr. Seung-Ki Baek, CEO of QuadMedicine   June 17, 2019 – SEOUL, South Korea. Today IVI exchanged a memorandum of understanding with QuadMedicine, a Korea-based biotech venture, to collaborate on the development of microneedle-based vaccines. With […]

  The Australian Broadcasting Corporation (ABC) carried a story on the new global push to develop the world’s first vaccine against Strep A in the wake of Wellcome Trust’s US$2.25 million grant to IVI and the Murdoch Children’s Research Institute. – Ed.   For most […]

Dr. Doo-Jin Kim, Senior Researcher, Infectious Disease Research Center at the Korea Research Institute of Bioscience & Biotechnology (KRIBB)   Dr. Doo-Jin Kim, Ph.D., Senior Researcher from the Infectious Disease Research Center of the Korea Research Institute of Bioscience & Biotechnology, delivered a lecture entitled: […]

  May 27, 2019, SEOUL, South Korea – Today marks the official kick-off meeting of the CAPTURA (‘Capturing Data on Antimicrobial Resistance Patterns and Trends in Use in Regions of Asia’) project, an international consortium led by IVI. This 2-day workshop brings together partners including […]

Dr. Julia Lynch and other panel members (Dr Firdausi Quadri, Senior Scientist, Infectious Diseases Division, icddr,b; Professor Ann-Mari Svennerholm, Gothenburg University) in discussion during the first session Development Talk at Sida Science Days 2019   IVI’s Deputy Director General of Development & Delivery, Dr. Julia […]

  On May 17, IVI’s COO, Francois Belin addressed members of Rotary International District 3640 at their annual Convention in Seoul, Korea and thanked them for their important contributions. IVI’s partnership with Rotary 3640 began back in 2016 with the signing of an MOU which […]

  On May 16, 2019, IVI was honored to receive a delegation from China National Biotec Group Company Limited (CNBG), China’s biggest vaccine manufacturer. Led by its President, Mr. WU Yonglin, CNBG and IVI discussed possibilities for collaborating to increase the impact of CNBG’s vaccines […]

  Ms. Joanne Lee, former Vice President of the Korea Support Committee for IVI and former Chairperson of the IVI Fundraising Campaign Committee (2005-2006), donated 50 million KRW (US$42,000) via KSC to support IVI’s vaccine research and development. Ms. Lee, who is currently based in […]

  As part of IVI’s commitment to environmental protection and combating climate change, IVI hosted an Environmental Impact Assessment workshop with the Swedish consultants Goodpoint on May 7, 2019. IVI and Goodpoint are working together on the development of an IVI environmental management plan.  

Dr. Raymond Hutubessy with Dr. Vittal Mogasale, Head of IVI’s Policy & Economic Research Department   On April 29, IVI welcomed Dr. Raymond Hutubessy, Senior Economist from the Immunization, Vaccines and Biologicals (IVB), Initiative for Vaccine Research (IVR) at the World Health Organization Headquarters, in Geneva, Switzerland, as […]

  Dr. Soon-Hwan Kwon, Ph.D., Armed Forces Medical Research Institute (AFMRI), gave a lecture entitled “Analysis of adenovirus genotypes and neutralization effects between genotypes” as part of the 2019 IVI Seminar Series: The Present and Future of Vaccine Development, at IVI headquarters in Seoul on […]

  On April 25, IVI welcomed a 6-person delegation from the National Institute of Food and Drug SafetyEvaluation (NIFDS) under the Korean Ministry of Food & Drug Safety at our headquarters in Seoul.  They visited IVI to explore potential opportunities in vaccine R&D collaboration as part of NIFDS’ efforts to improve Korea’s vaccine self-sufficiency.

  This week (April 24 – 30) is World Immunization Week 2019. On this occasion, IVI is pleased to present a feature video introducing joint efforts by international partners to accelerate the use of Japanese encephalitis (JE) vaccine among children across Asia.   Japanese Encephalitis […]

IVI’s Director General, Dr. Jerome Kim was a member of the team of experts that looked at the underfunding of rheumatic heart disease (RHD) research.   RHD, a long-term consequence of Streptococcus pyogenes (Group A streptococcus, or GAS) infection, is estimated to affect at least 33 […]

Dr. Baik Yeong-Ok, CEO of EuBiologics, and Dr. Jerome Kim, Director General of IVI pose together at the inauguration of EuBiologics’ Second Plant in Chuncheon, Korea on April 9, 2019.   EuBiologics, the manufacturer of Euvichol® and Euvichol-Plus® oral cholera vaccine, and an important partner […]

Key attendees pose for a commemorative photo   Dr. Jerome Kim delivers his keynote address   IVI Director General Dr. Jerome Kim was invited as a keynote speaker at the ‘International Symposium on Epidemics Preparedness Using ICT’ at the Korean National Assembly on April 3, […]

  IVI has been featured in Seoul Foreign School’s Work Experience Program brochure. In May of 2018, eleven SFS students participated in the program with support from volunteer Dr. Silvia Kim. They learned basic techniques in cellular immunology in the IVI labs and had the […]

The Seoul Economic Daily published an article in Korean about the Korean vaccine industry. The article describes the growth of the Korean vaccine industry and has two favorable mentions of IVI’s role. Shown below is a translation of the article. –Ed.   Korean vaccines expanding global territory […]

The Hankook Ilbo, a leading general daily in Korea, has published an op-ed written by IVI Director General Dr. Jerome Kim. He urges Korean leaders to be the voice of the neglected to support development of vaccines against ‘tropical neglected diseases.’ — Ed.   Neglected […]

Prof. Lee Kun-hwa gives lecture at IVI Prof. Keun Hwa Lee from Jeju National University in Korea delivered a lecture entitled ‘Epidemiology of Severe Fever with Thrombocytopenia Syndrome Virus’ as part of the IVI Seminar series on March 26, 2019. The seminar was sponsored by […]

IVI Director General Dr. Jerome Kim gives his talk entitled ‘The Challenge of Bacterial Vaccines for Global Health’ at the BactiVac 2nd Annual Network Meeting. IVI Director General, Dr. Jerome Kim delivered a talk on The Challenge of Bacterial Vaccines for Global Health at the BactiVac 2nd […]

What follows is a story about the collaboration between the Global Disease Eradication Fund (managed by KOICA), IVI, and our partners to protect the vulnerable from a deadly infectious disease. It connects our shared mission to make a positive difference in global public health with […]

  Several members of the IVI Board of Trustees and its Scientific Advisory Group pose for a photo at a diner held at the College of Physicians in Philadelphia on February 27, 2019 on the occasion of the ‘Improving Global Health – A Symposium Honoring […]

IVI Director General, Dr. Jerome Kim (right) shakes hands with Prof. Jeon-Soo Shin from Yonsei University College of Medicine’s IIID as they exchange MOU at IVI on February 12, 2019.   On February 12 IVI exchanged a memorandum of understanding with the Institute of Immunology […]

Dr. Julie Ake (center), Dr. Sandhya Vasan (left) with IVI Director General Dr. Jerome Kim at IVI headquarters on January 28 IVI was pleased and privileged to welcome a delegation consisting of Dr. Julie Ake, Deputy Director, US Military HIV Research Program (MHRP) at the […]

Reason for measles outbreak in “measles free” Korea By Jerome Kim, Director General, International Vaccine Institute   In 2014, the World Health Organization declared Korea “measles free” –yet, in 2019 an outbreak of measles in the country has affected 37 patients.  Similarly, the United States […]

31 cases reported of a ‘forgotten disease’ –the measles, due to vaccine aversion SBS TV, January 15, 2019   A new measles patient has been reported in Ansan, Gyeonggi Province. It is a three-year-old girl who has not been vaccinated. Experts claim that measles cases […]

We are pleased to share IVI Director General Dr. Jerome Kim’s First Opinion Editorial: “‘Neglected diseases’ are anything but neglected by the billion-plus people living with them,” which was published recently in STAT News, a major news portal in health and science. Read the article as […]

This month, partners of the Global Task Force on Cholera Control (GTFCC) mark one year since the launch of Ending Cholera: A Global Roadmap to 2030, which targets a 90% reduction in cholera deaths by 2030 and the elimination of cholera in at least 20 […]

Cholera is an acute diarrheal infection caused by ingestion of food or water contaminated with the bacterium Vibrio cholerae. It affects both children and adults and can kill within hours if not properly treated.  According to the WHO, there are 1.4 to 4.3 million cases […]

IVI’s Biostatistics and Data Management Department (BDM) is hosting a training course on the Vaccine Adverse Events Information Monitoring System (VAEIMS) on September 17-19, 2018. The VAEIMS training, coordinated by the Regional office of the WHO Western Pacific Region, will bring together seven national regulatory […]

2018 International Vaccine Industry Forum The 2018 International Vaccine Industry Forum took place September 7-8 at the Dragon City Hotel in Seoul, Korea. The event was co-hosted by Gyeongsangbuk Province, Andong City, and Rep. Kim Kwang-rim of the National Assembly, and organized jointly by IVI […]

Training course on Vaccine Adverse Events Information Monitoring System (VAEIMS) IVI, Seoul, Korea, 17-19 SEP 2018 Final Agenda (v1.4) COURSE OVERVIEW The focus of this course is to develop an understanding of the vaccine adverse events information monitoring system (VAEIMS) and medical coding of vaccine […]

From left to right:  Dr. KH Kim, Ambassador at Large for Liberia; Dr. Kyung Taik Han, IVI Deputy Director General for Government and Global Affairs; Ms. Piang Chit Kim; Mr. Uddav Neupane, Embassy of Nepal; Ms. Soyeun Park, Embassy of the Netherlands; Dr. Julie Lynch, […]

On Saturday, August 25, 2018, IVI was honored to be on the receiving end of yet another generous outpouring of support by professional Violinist Lee Sang Hee, in the form of her 15th consecutive charity concert. This year’s ‘Lee Sang Hee Violin Recital with IVI’ […]

On August 17, IVI welcomed participants of the Infectious Disease Field Management Training (IDFMT) program, which is supported by KOICA as part of the Global Health Security Agenda (GHSA) program; as well as students from Yonsei University’s 2018 Master’s Degree Program in Global Health Security […]

– Mass vaccination campaign conducted by Indonesian authorities with IVI support protects nearly 1 million children from JE – Partners join forces to measure long-term vaccine effectiveness to accelerate JE vaccine’s introduction in Indonesia and other Asian endemic regions   We are pleased to announce […]

Mr. George Bickerstaff elected Chair of IVI Board of Trustees, Dr. Hanna Nohynek Vice-Chair     The International Vaccine Institute (IVI) today announced that Mr. George Bickerstaff, currently Vice-Chair and Board member since 2009, has been elected as the new Chair of the Board of […]

IVI joins forces with partners to support accelerated vaccination against Japanese encephalitis in Indonesian children – To support JE surveillance to evaluate vaccine effectiveness following vaccination of 960,000 children in Bali by the Indonesian government – LG Electronics donates diagnostic kits for 4-year post-vaccination surveillance […]

Chiang Mai University medical and health science professionals’ visit to IVI A group of medical and health science professionals from Chiang Mai University in Thailand visited IVI on April 12, as part of an international joint program for infectious diseases led by the Seoul National University Hospital. […]

‘Vaccine investment brings 16-fold return… ; partnering with Bill Gates’ Jerome Kim, Director General, International Vaccine Institute Marking 20th anniversary of endeavors for development and delivery of vaccines such as cholera vaccine By Kim Sung-mo The Chosun Ilbo, October 10, 2017 “Investment in vaccines is […]

Borderless investment in vaccines to counter borderless infectious diseases The Kyunghyang Shinmun daily Opinion October 13, 2017 Jerome Kim, MD, Director General, International Vaccine Institute (IVI) Outbreaks of Ebola, MERS and SARS have killed tens of thousands of people around the world. Diseases like these […]

Korea’s role to eradicate AIDS By Jerome Kim, Director General, International Vaccine Institute (IVI) Maeil Business Newspaper, 2017/12/01   Today is World AIDS Day, and it has been 36 years since the first report of a cluster infections with an unusual germ, then called “PCP”, […]

July 28, 2017, SEOUL, KOREA – Prof. Ban Ki-moon, former Secretary-General of the United Nations, visited the International Vaccine Institute (IVI) at Seoul National University (SNU) Research Park on July 28. The former UN chief is currently Honorary Dean of the Institute for Global Engagement […]

Sed laoreet, ante in dictum iaculis, nisl ante feugiat metus, vitae scelerisque ipsum enim quis risus. Aliquam vel euismod augue, at imperdiet eros. Ut tellus lorem, mollis et massa quis, rhoncus pretium magna. Praesent tortor dui, mollis a risus vel, malesuada ornare libero. Quisque feugiat […]

Fusce magna nulla, ullamcorper at dictum vel, faucibus sit amet tellus. Morbi aliquam dui nec orci euismod, sit amet ornare turpis commodo. Phasellus a varius odio. Cras lobortis odio ac hendrerit ultricies. Nam accumsan aliquet diam, id interdum nisi molestie ut. Sed bibendum ex ligula, […]

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec elit tellus, commodo ut mauris sit amet, tristique auctor nisi. Nam elementum, nibh vel fermentum fringilla, magna sem congue tellus, nec maximus mi libero sed justo. Ut molestie non sem eget rhoncus. Mauris efficitur mi et […]

The International Vaccine Institute (IVI) is an international nonprofit organization that was founded on the belief that the health of children in developing countries can be dramatically improved by the use of new and improved vaccines. Working in collaboration with the international scientific community, public […]